147 related articles for article (PubMed ID: 20095042)
1. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer.
Lu YJ; Wu CS; Li HP; Liu HP; Lu CY; Leu YW; Wang CS; Chen LC; Lin KH; Chang YS
Genes Chromosomes Cancer; 2010 May; 49(5):412-24. PubMed ID: 20095042
[TBL] [Abstract][Full Text] [Related]
2. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
[TBL] [Abstract][Full Text] [Related]
3. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer.
Kim M; Kim JH; Jang HR; Kim HM; Lee CW; Noh SM; Song KS; Cho JS; Jeong HY; Hahn Y; Yeom YI; Yoo HS; Kim YS
Cancer Res; 2008 Sep; 68(17):7147-55. PubMed ID: 18757430
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
6. Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.
Nakagawa T; Pimkhaokham A; Suzuki E; Omura K; Inazawa J; Imoto I
Cancer Sci; 2006 Oct; 97(10):1070-4. PubMed ID: 16918994
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
[TBL] [Abstract][Full Text] [Related]
9. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
[TBL] [Abstract][Full Text] [Related]
10. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
11. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer.
Wu CS; Lu YJ; Li HP; Hsueh C; Lu CY; Leu YW; Liu HP; Lin KH; Hui-Ming Huang T; Chang YS
Int J Cancer; 2010 Jun; 126(11):2542-52. PubMed ID: 19824040
[TBL] [Abstract][Full Text] [Related]
12. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M
Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
16. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
18. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
20. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T
Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
